Cryoprecipitate: An outmoded treatment?

Transfusion Medicine

Volumn 22, Issue 5, 2012, Pages 315-320

  Yang, L ^a   Stanworth, S ^b   Baglin, T ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Bleeding; Coagulopathy; Cryoprecipitate; Fibrinogen

Indexed keywords

FIBRINOGEN; FIBRINOGEN CONCENTRATE; FRESH FROZEN PLASMA; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; HETASTARCH; METHYLENE BLUE;

ACIDOSIS; BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD GROUP ABO INCOMPATIBILITY; CREUTZFELDT JAKOB DISEASE; CRYOPRECIPITATE; FIBRIN CLOT; FIBRINOGEN DEFECT; GENE MUTATION; HEMOPHILIA; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPOFIBRINOGENAEMIA; HYPOTHERMIA; INJURY; LIVER FAILURE; LUNG EMBOLISM; PREDICTIVE VALUE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; THAWING; THROMBOELASTOGRAPHY; TRANSFUSION RELATED ACUTE LUNG INJURY; VEIN THROMBOSIS; WOUND HEALING IMPAIRMENT;

AFIBRINOGENEMIA; FACTOR VIII; FACTOR XIII; FIBRINOGEN; FIBRONECTINS; HEMORRHAGE; HISTORY, 20TH CENTURY; HUMANS; VON WILLEBRAND FACTOR;

EID: 84866548121     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/j.1365-3148.2012.01181.x     Document Type: Review

References (37)

1. Afshari, A., Wikkelso, A., Brok, J., Moller, A.M. & Wetterslev, J. (2011) Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion. Cochrane Database of Systematic Reviews, 3, CD007871.
2. AFSSAPS: Agence française de sécurité sanitaire des produits de santé. (2011) L'Afssaps recommande l'arrêt progressif de l'utilisation du plasma thérapeutique traité par le bleu de méthylène. [Online]. Available: http://www.ansm.sante.fr/var/ansm_site/storage/original/application/5929de2c69988c350f277e5053a5b64b.pdf (Accessed April 2012).
3. Barrett, K.E., Israels, M.C. & Burn, A.M. (1967) The effect of cryoprecipitate concentrate in patients with classical haemophilia. The Lancet, 1, 191-192.
4. Bennett, E. & Dormandy, K. (1966) Pool's cryoprecipitate and exhausted plasma in the treatment of von Willebrand's disease and factor-XI deficiency. The Lancet, 2, 731-732.
5. Besser, M.W. & Klein, A.A. (2010) The coagulopathy of cardiopulmonary bypass. Critical Reviews in Clinical Laboratory Sciences, 47, 197-212.
6. Charbit, B., Mandelbrot, L., Samain, E. et al. (2007) The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. Journal of Thrombosis and Haemostasis, 5, 266-273.
7. Ciavarella, D., Reed, R.L., Counts, R.B., Baron, L., Pavlin, E., Heimbach, D.M. & Carrico, C.J. (1987) Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patient. British Journal of Haematology, 67, 365-368.
8. Danes, A.F., Cuenca, L.G., Bueno, S.R., Mendarte Barrenechea, L. & Ronsano, J.B. (2008) Efficacy and tolerability of human fibrinogen concentrate administration to patients with acquired fibrinogen deficiency and active or in high-risk severe bleeding. Vox Sanguinis, 94, 221-226.
9. Dickneite, G., Pragst, I., Joch, C. & Bergman, G.E. (2009) Animal model and clinical evidence indicating low thrombogenic potential of fibrinogen concentrate (Haemocomplettan P). Blood Coagulation & Fibrinolysis, 20, 535-540.
10. Ehmann, W.C. & al-Mondhiry, H. (1994) Congenital afibrinogenemia and splenic rupture. The American Journal of Medicine, 96, 92-94.
11. Fenger-Eriksen, C., Jensen, T.M., Kristensen, B.S., Jensen, K.M., Tønnesen, E., Ingerslev, J. & Sørensen, B. (2009) Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial. Journal of Thrombosis and Haemostasis, 7, 795-802.
12. French, C.J., Bellomo, R. & Angus, P. (2003) Cryoprecipitate for the correction of coagulopathy associated with liver disease. Anaesthesia and Intensive Care, 31, 357-361.
13. Fries, D. & Martini, W.Z. (2010) Role of fibrinogen in trauma-induced coagulopathy. British Journal of Anaesthesia, 105, 116-121.
14. Gill, R., Herbertson, M., Vuylsteke, A. et al. (2009) Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery. Circulation, 120, 21-27.
15. Girolami, A., Vettore, S., Ruzzon, E., Marinis, G.B. & Fabris, F. (2012) Rare unusual bleeding manifestations in congenital bleeding disorders: an annotated review. Clinical and Applied Thrombosis/Hemostasis, 18, 121-127.
16. Karlsson, M., Ternström, L., Hyllner, M., Baghaei, F., Nilsson, S. & Jeppsson, A. (2008) Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery: a prospective observational study. Transfusion, 48, 2152-2158.
17. Karlsson, M., Ternström, L., Hyllner, M., Baghaei, F., Flinck, A., Skrtic, S. & Jeppsson, A. (2009) Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. Thrombosis and Haemostasis, 102, 137-144.
18. Knowles, S., Cohen, H., on behalf of the Serious Hazards of Transfusion Steering Group (2011) The 2010 Annual SHOT Report.
19. Kreuz, W., Meili, E., Petersalonen, K., Haertel, S., Devay, J., Krzensk, U. & Egbring, R. (2005) Efficacy and tolerability of a pasteurised human fibrinogen concentrate in patients with congenital fibrinogen deficiency. Transfusion and Apheresis Science, 32, 247-253.
20. Martini, W.Z. (2007) The effects of hypothermia on fibrinogen metabolism and coagulation function in swine. Metabolism, 56, 214-221.
21. Martini, W.Z. & Holcomb, J.B. (2007) Acidosis and coagulopathy: the differential effects on fibrinogen synthesis and breakdown in pigs. Annals of Surgery, 246, 831-835.
22. Moganasundram, S., Hunt, B.J., Sykes, K. et al. (2010) The relationship among thromboelastography, hemostatic variables, and bleeding after cardiopulmonary bypass surgery in children. Anesthesia and Analgesia, 110, 995-1002.
23. Nascimento, B., Rizoli, S., Rubenfeld, G., Fukushima, R., Ahmed, N., Nathens, A., Lin, Y. & Callum, J. (2011) Cryoprecipitate transfusion: assessing appropriateness and dosing in trauma. Transfusion Medicine, 21, 394-401.
24. O'Shaughnessy, D.F., Atterbury, C., Bolton Maggs, P., Murphy, M., Thomas, D., Yates, S., Williamson, L.M.B. & Committee for Standards in Haematology, Blood Transfusion Task Force (2004) Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. British Journal of Haematology, 126, 11-28.
25. Pool, J.G., Gershgold, E.J. & Pappenhagen, A.R. (1964) High-potency antihaemophilic factor concentrate prepared from cryoglobulin precipitate. Nature, 203, 312.
26. Reinhart, W.H. (2003) Fibrinogen - marker or mediator of vascular disease? Vascular Medicine, 8, 211-216.
27. Rourke, C., Curry, N., Khan, S., Taylor, R., Raza, I., Davenport, R., Stanworth, S. & Brohi, K. (2012) Fibrinogen levels during trauma hemorrhage, response to replacement therapy and association with patient outcomes. Journal of Thrombosis and Haemostasis 10, 1342-1351.
28. Schneider, D., Taatjes, D., Howard, D. & Sobel, B. (1999) Increased reactivity of platelets induced by fibrinogen independent of its binding to the IIb-IIIa surface glycoprotein: a potential contributor to cardiovascular risk. Journal of the American College of Cardiology, 33, 261-266.
29. Schochl, H., Forster, L., Woidke, R., Solomon, C. & Voelckel, W. (2010) Use of rotation thromboelastometry (ROTEM) to achieve successful treatment of polytrauma with fibrinogen concentrate and prothrombin complex concentrate. Anaesthesia, 65, 199-203.
30. Schochl, H., Cotton, B., Inaba, K., Nienaber, U., Fischer, H., Voelckel, W. & Solomon, C. (2011) FIBTEM provides early prediction of massive transfusion in trauma. Critical Care, 15, R265.
31. Shima, M., Tanaka, I., Sawamoto, Y., Kanehiro, H., Matsuo, N., Nishimura, A., Giddings, J.C. & Yoshioka, A. (1997) Successful treatment of two brothers with congenital afibrinogenemia for splenic rupture using heat- and solvent detergent-treated fibrinogen concentrates. Journal of Pediatric Hematology/Oncology, 19, 462-465.
32. Simon, L., Santi, T.M., Sacquin, P. & Hamza, J. (1997) Pre-anaesthetic assessment of coagulation abnormalities in obstetric patients: usefulness, timing and clinical implications. British Journal of Anaesthesia, 78, 678-683.
33. Sørensen, B. & Bevan, D. (2010) A critical evaluation of cryoprecipitate for replacement of fibrinogen. British Journal of Haematology, 149, 834-843.
34. Stanworth, S.J., Brunskill, S.J., Hyde, C.J., McClelland, D.B.L. & Murphy, M.F. (2004) Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. British Journal of Haematology, 126, 139-152.
35. Stinger, H.K., Spinella, P.C., Perkins, J.G. et al. (2008) The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. The Journal of Trauma, 64, S79-S85.
36. Tauber, H., Innerhofer, P., Breitkopf, R., Westermann, I., Beer, R., El Attal, R., Strasak, A. & Mittermayr, M. (2011) Prevalence and impact of abnormal ROTEM® assays in severe blunt trauma: results of the 'Diagnosis and Treatment of Trauma-Induced coagulopathy (DIA-TRE-TIC) study'. British Journal of Anaesthesia, 107, 378-387.
37. Yang, L., Stanworth, S., Hopewell, S., Doree, C. & Murphy, M. (2012) Is fresh-frozen plasma clinically effective? An update of a systematic review of randomized controlled trials. Transfusion 52, 1673-1686.